ZLZhongyue Liu

Zhongyue Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhongyue Liu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Chao Tu

    Department of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, China

    1 shared publication
  • Lin Mei

    Department of Orthopedics The Second Xiangya Hospital of Central South University Changsha Hunan China

    1 shared publication
  • Ruiling Xu

    Department of Orthopaedics, The Second XiangYa Hospital, Central South University, Changsha, China

    1 shared publication
  • Ruiqi Chen

    Department of Orthopedics The Second Xiangya Hospital of Central South University Changsha Hunan China

    1 shared publication
  • Xiaofeng Gong

    Nanchang University 1 The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, Institute of Organoid Research, School of Basic Medical Sciences, Institute of Biomedical Innovation, The First Affiliated Hospital, Jiangxi Medical College Nanchang, China

    1 shared publication
  • Xiaolei Ren

    Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China

    1 shared publication

Latest Publications

  • 3D Models of Sarcomas: The Next-generation Tool for Personalized Medicine

    by Ruiling Xu, Ruiqi Chen, Chao Tu, Xiaofeng Gong, Zhongyue Liu, Lin Mei, Xiaolei Ren, Zhihong Li

    Sarcoma is a complex and heterogeneous cancer that has been difficult to study in vitro. While two-dimensional (2D) cell cultures and mouse models have been the dominant research tools, three-dimensional (3D) culture systems such as organoids have emerged as promising alternatives. In this review, we discuss recent developments in sarcoma organoid culture, with a focus on their potential as tools for drug screening and biobanking. We also highlight the ways in which sarcoma organoids have been used to investigate the mechanisms of gene regulation, drug resistance, metastasis, and immune interactions. Sarcoma organoids have shown to retain characteristics of in vivo biology within an in vitro system, making them a more representative model for sarcoma research. Our review suggests that sarcoma organoids offer a potential path forward for translational research in this field and may provide a platform for developing personalized therapies for sarcoma patients.